The Foundation for Prader-Willi Research (FPWR) is committed to funding research to advance the understanding and treatment of Prader-Willi syndrome (PWS). FPWR focuses on supporting innovative projects to find new treatments that alleviate the symptoms associated with PWS, aiming to improve the lives of those affected by this condition.
FPWR's Grant Program aims to encourage research projects that will contribute to new treatments for Prader-Willi syndrome (PWS), focusing on a better understanding of the disorder and improving quality of life for those affected. The program supports a wide range of research areas including the genetics of PWS, neurobiology of hunger/feeding behavior, cognitive deficits, maladaptive behavior, mental illness, clinical care research, and the development of therapeutic strategies such as genetic therapies, novel pharmaceuticals, and drug repurposing. Applicants can request up to $150,000 USD for up to 18 months, with the possibility of renewal for another 18 months. Projects that are considered higher risk or highly innovative may opt for a smaller budget or shorter duration.